Up a level |
Jamali, A and Mahdavi, M and Hassan, Z.M and Sabahi, F and Farsani, M.J and Bamdad, T and Soleimanjahi, H and Motazakker, M and Shahabi, SH (2009) A novel adjuvant, the general opioid antagonist naloxone, elicits a robust cellular immune response for a DNA vaccine. International Immunology, 21 (3). pp. 217-225.